Herbal medicine : chaos in the marketplace /
Americans seeking herbal medicines now face confusion and even danger. There is great potential for these medicines to improve the health of consumers--if current regulations can be revised!Herbal Medicine: Chaos in the Marketplace is a prize-winning critique of the regulation and business of herbal...
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
New York :
Haworth Herbal Press,
[2003]
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Part II Review of Regulations
- Chapter 2. United States 9
- History of Regulation of Botanicals 9
- Current Legal Classification of Botanicals 29
- Current Regulation and Surveillance of Botanicals 37
- Chapter 3. Canada 63
- Legal Classification 66
- Proof of Safety and Efficacy 69
- Manufacturing Standards 74
- Labeling, Advertising, Distribution, and Retail Sale 76
- Postmarket Safety and Surveillance 79
- Chapter 4. Germany 81
- Legal Classification 81
- Proof of Safety and Efficacy 81
- Manufacturing Standards 86
- Labeling, Advertising, Distribution, and Retail Sale 86
- Postmarket Safety and Surveillance 87
- Chapter 5. France 89
- Legal Classification 89
- Proof of Safety and Efficacy 89
- Manufacturing Standards 91
- Labeling, Advertising, Distribution, and Retail Sale 91
- Postmarket Safety and Surveillance 91
- Chapter 6. United Kingdom 93
- Legal Classification 93
- Proof of Safety and Efficacy 94
- Manufacturing Standards 95
- Labeling, Advertising, Distribution, and Retail Sale 95
- Postmarket Safety and Surveillance 96
- Chapter 7. Summary of International Regulatory Review 97
- Part III Illustrative Examples
- Chapter 8. Examples with Potential Public Health Benefits 103
- St. John's Wort and Moderate Depression 103
- Ginkgo and Alzheimer's Disease 108
- Echinacea and the Common Cold 109
- Chapter 9. Examples That Present Public Health Risks 113
- Ephedra 113
- Adulteration Case Report 115
- Comfrey 116
- Part IV Analysis of Current and Potential Impact on Public Health
- Chapter 10. Safety 121
- Absence of Premarket Approval 121
- Postmarket Surveillance 124
- Chapter 11. Research 127
- Patent Protection 127
- Product-Specific Research by Manufacturers 128
- Government Research Funding 129
- Epidemiological Research 130
- Chapter 12. Clinical Practice, Managed Care, and Health Insurance 133
- Education of Medical Professionals 133
- Coordination of Treatment 134
- Access to Botanical Treatment 135
- Opportunities for Cost Savings 135
- Chapter 13. Consumer Interests 137
- Consumers As a Political Force 137
- Sorting Through the Morass 138
- Chapter 14. The Roles of Business, Media, and the Government 145
- Chapter 15. Summary and Recommendations 155
- Appendix A. U.S. Dietary Supplement Health and Education Act of 1994 161
- Appendix B. Recommendations of the Canadian Standing Committee on Health 175.